Clinical and Applied Thrombosis/Hemostasis · 2000 · 17 citations · 9 references
MedicineHematologyObstetricsHigh-risk PregnancyMaternal-fetal MedicineObstetric ComplicationsAntithrombotic TherapyPregnancyThromboembolic DiseaseThromboembolism PreventionThrombosisThrombosis PreventionAnticoagulant Use In PregnancyAnticoagulation In PregnancyLow-molecular-weight Heparin TherapyPregnancy-associated ThrombocytopeniaPregnancy-associated ThromboprophylaxisPregnancy-associated Venous ThromboembolismThrombocytopenia In PregnancyThrombosis Prevention In Pregnancy
There is no consensus concerning thromboembolic prophylaxis in high-risk pregnant women with a previous history of heparin-induced thrombocytopenia. An alternative anticoagulant therapy is danaparoïd, whereas unfractioned and low-molecular-weight heparin therapy is contraindicated. We report a case of successful thrombosis prophylaxis using danaparoïd in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia during a previous pregnancy and Widal's disease.
9